Search Results - "Pullambhatla, Mrudula"

2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer by YING CHEN, PULLAMBHATLA, Mrudula, FOSS, Catherine A, BYUN, Youngjoo, NIMMAGADDA, Sridhar, SENTHAMIZHCHELVAN, Srinivasan, SGOUROS, George, MEASE, Ronnie C, POMPER, Martin G

“…We have synthesized and evaluated in vivo 2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [(18)F]DCFPyL, as…”
Get full text

A low molecular weight PSMA-based fluorescent imaging agent for cancer by Chen, Ying, Dhara, Surajit, Banerjee, Sangeeta Ray, Byun, Youngjoo, Pullambhatla, Mrudula, Mease, Ronnie C., Pomper, Martin G.

“…We synthesized YC-27 3 to provide a fluorescent imaging agent for the prostate-specific membrane antigen (PSMA), a marker for hormone-independent prostate…”
Get full text

Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen by Chen, Ying, Pullambhatla, Mrudula, Banerjee, Sangeeta R, Byun, Youngjoo, Stathis, Marigo, Rojas, Camilo, Slusher, Barbara S, Mease, Ronnie C, Pomper, Martin G

“…Targeted near-infrared (NIR) optical imaging can be used in vivo to detect specific tissues, including malignant cells. A series of NIR fluorescent ligands…”
Get full text

Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer by Chen, Ying, Foss, Catherine A, Byun, Youngjoo, Nimmagadda, Sridhar, Pullambhatla, Mrudula, Fox, James J, Castanares, Mark, Lupold, Shawn E, Babich, John W, Mease, Ronnie C, Pomper, Martin G

“…To extend our development of new imaging agents targeting the prostate-specific membrane antigen (PSMA), we have used the versatile intermediate…”
Get full text

A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA) by Banerjee, Sangeeta Ray, Pullambhatla, Mrudula, Shallal, Hassan, Lisok, Ala, Mease, Ronnie C, Pomper, Martin G

“…We have developed a modular scaffold for preparing high-affinity, homo-multivalent inhibitors of the prostate-specific membrane antigen (PSMA) for imaging and…”
Get full text

Influence of Bioluminescence Imaging Dynamics by D-Luciferin Uptake and Efflux Mechanisms by Zhang, Yimao, Pullambhatla, Mrudula, Laterra, John, Pomper, Martin G.

“…Bioluminescence imaging (BLI) detects light generated by luciferase-mediated oxidation of substrate and is used widely for evaluating transgene expression in…”
Get full text

Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA) by Ray Banerjee, Sangeeta, Pullambhatla, Mrudula, Foss, Catherine A, Falk, Alexander, Byun, Youngjoo, Nimmagadda, Sridhar, Mease, Ronnie C, Pomper, Martin G

“…Technetium-99m, the most commonly used radionuclide in nuclear medicine, can be attached to biologically important molecules through a variety of chelating…”
Get full text

Synthesis and biological evaluation of substrate-based imaging agents for the prostate-specific membrane antigen by Byun, Youngjoo, Pullambhatla, Mrudula, Wang, Haofan, Mease, Ronnie C., Pomper, Martin G.

“…Prostate-specific membrane antigen (PSMA) is an attractive target for the imaging of prostate cancer (PCa) due to the elevated expression on the surface of…”
Get full text

68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer by Banerjee, Sangeeta Ray, Pullambhatla, Mrudula, Byun, Youngjoo, Nimmagadda, Sridhar, Green, Gilbert, Fox, James J, Horti, Andrew, Mease, Ronnie C, Pomper, Martin G

“…Gallium-68 is a generator-produced radionuclide for positron emission tomography (PET) that is being increasingly used for radiolabeling of tumor-targeting…”
Get full text

Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists by Roy, Somak, Coldren, Christopher, Karunamurthy, Arivarasan, Kip, Nefize S, Klee, Eric W, Lincoln, Stephen E, Leon, Annette, Pullambhatla, Mrudula, Temple-Smolkin, Robyn L, Voelkerding, Karl V, Wang, Chen, Carter, Alexis B

“…Bioinformatics pipelines are an integral component of next-generation sequencing (NGS). Processing raw sequence data to detect genomic alterations has…”
Get full text

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen by Kiess, Ana P, Minn, Il, Chen, Ying, Hobbs, Robert, Sgouros, George, Mease, Ronnie C, Pullambhatla, Mrudula, Shen, Colette J, Foss, Catherine A, Pomper, Martin G

“…Auger electron emitters such as (125)I have a high linear energy transfer and short range of emission (<10 μm), making them suitable for treating…”
Get full text

Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines by Li, Marilyn M., Cottrell, Catherine E., Pullambhatla, Mrudula, Roy, Somak, Temple-Smolkin, Robyn L., Turner, Scott A., Wang, Kai, Zhou, Yunyun, Vnencak-Jones, Cindy L.

“…To assess the clinical implementation of the 2017 Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint…”
Get full text

111 In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues by Banerjee, Sangeeta R, Foss, Catherine A, Horhota, Allen, Pullambhatla, Mrudula, McDonnell, Kevin, Zale, Stephen, Pomper, Martin G

“…Targeted delivery of drug-encapsulated nanoparticles is a promising new approach to safe and effective therapeutics for cancer. Here we investigate the…”
Get full text

Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA by Ray Banerjee, Sangeeta, Chen, Zhengping, Pullambhatla, Mrudula, Lisok, Ala, Chen, Jian, Mease, Ronnie C, Pomper, Martin G

“…(68)Ga-labeled, low-molecular-weight imaging agents that target the prostate-specific membrane antigen (PSMA) are increasingly used clinically to detect…”
Get full text

Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer by Banerjee, Sangeeta Ray, Pullambhatla, Mrudula, Foss, Catherine A, Nimmagadda, Sridhar, Ferdani, Riccardo, Anderson, Carolyn J, Mease, Ronnie C, Pomper, Martin G

“…Prostate-specific membrane antigen (PSMA) is a well-recognized target for identification and therapy of a variety of cancers. Here we report five…”
Get full text

Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms: A Report of the Association for Molecular Pathology by McClure, Rebecca F, Ewalt, Mark D, Crow, Jennifer, Temple-Smolkin, Robyn L, Pullambhatla, Mrudula, Sargent, Rachel, Kim, Annette S

“…To address the clinical relevance of small DNA variants in chronic myeloid neoplasms (CMNs), an Association for Molecular Pathology Working Group…”
Get full text

Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT by Nimmagadda, Sridhar, Pullambhatla, Mrudula, Pomper, Martin G

“…Chemokine receptor 4 (CXCR4) is expressed in a variety of cancers, including breast, brain, ovarian, and prostate. CXCR4-CXCL12 interactions are critical for…”
Get full text

Synthesis and Evaluation of Gd III ‐Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate‐Specific Membrane Antigen by Banerjee, Sangeeta Ray, Ngen, Ethel J., Rotz, Matthew W., Kakkad, Samata, Lisok, Ala, Pracitto, Richard, Pullambhatla, Mrudula, Chen, Zhengping, Shah, Tariq, Artemov, Dmitri, Meade, Thomas J., Bhujwalla, Zaver M., Pomper, Martin G.

“…Abstract Magnetic resonance (MR) imaging is advantageous because it concurrently provides anatomic, functional, and molecular information. MR molecular imaging…”
Get full text

Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography by NIMMAGADDA, Sridhar, PULLAMBHATLA, Mrudula, STONE, Kristie, GREEN, Gilbert, BHUJWALLA, Zaver M, POMPER, Martin G

“…The chemokine receptor CXCR4 and its cognate ligand CXCL12 are pivotal for establishing metastases from many tumor types. Thus, CXCR4 may offer a cell surface…”
Get full text

Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists by Lockwood, Christina M, Borsu, Laetitia, Cankovic, Milena, Earle, Jonathan S L, Gocke, Christopher D, Hameed, Meera, Jordan, Danielle, Lopategui, Jean R, Pullambhatla, Mrudula, Reuther, Jacquelyn, Rumilla, Kandelaria M, Tafe, Laura J, Temple-Smolkin, Robyn L, Terraf, Panieh, Tsimberidou, Apostolia M

“…Diagnosing, selecting therapy for, and monitoring cancer in patients using a minimally invasive blood test represents a significant advance in precision…”
Get full text